3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
2
Completed
2
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
134
pembrolizumab
113
Pemetrexed
94
Cisplatin
88
durvalumab
63
Paclitaxel
60
osimertinib
54
Nivolumab
54
Docetaxel
44
atezolizumab
41
Etoposide
30
Radiotherapy
28
Radiosurgery
26
Gemcitabine
26
Specimen Handling
24
Ipilimumab
23
Taxes
19
Magnetic Resonance Spectroscopy
19
amivantamab
16
130-nm albumin-bound paclitaxel
16
Drug Therapy
15
Bevacizumab
15
Radiation
14
Platinum
14
Immunoglobulin G
14
Disulfides
14
cemiplimab
13
Crizotinib
13
Cyclophosphamide
12
Biopsy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
vistusertib
×
Thoracic
×
Clear all
NCT03334617
2025-10-27
HUDSON
AstraZeneca
Phase 2
Active not recruiting
528 enrolled
16 charts